Research progress of immune-related pneumonia caused by PD-1/PD-L1 inhibitor / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 627-629, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-863541
ABSTRACT
The incidence of immune-related pneumonia caused by programmed death-1/programmed death ligand-1 inhibitors is low, but the risk is high. Patients with non-small cell lung cancer who have pre-existing lung diseases or have received chest radiotherapy are more likely to develop pneumonia, but their clinical symptoms are not typical, which reduces the survival benefit of patients. Delaying immunotherapy early and rationally using glucocorticoids and immunosuppressants can relieve clinical symptoms and improve prognosis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS